Home The Active Ingredient Matrix Andrographis paniculata (Andrographolide)

Formulation Intelligence

Andrographis paniculata (Andrographolide)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Andrographis paniculata (Andrographolide).

Andrographolide is a diterpene lactone that exerts potent anti-inflammatory and immunomodulatory effects by inhibiting NF-κB signaling and reducing the production of pro-inflammatory cytokines, primarily targeted at mitigating upper respiratory tract infections.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

5318517

Molecular Weight

350.4 g/mol

XLogP3 (Lipophilicity)

2.2

IUPAC Name

(3E,4S)-3-[2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethylidene]-4-hydroxyoxolan-2-one

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

  • Eleutherococcus senticosus for synergistic adaptogenic and immune-stimulatory effects in acute respiratory distress
  • Sambucus nigra for enhanced antiviral activity via complementary neuraminidase inhibition and viral entry blockade

Biological Formulation Enhancers

  • Piperine for the inhibition of P-glycoprotein-mediated efflux and CYP3A4 metabolism to increase plasma concentration
  • Phosphatidylcholine for the creation of phytosome complexes to improve the intestinal permeability of the lipophilic lactone

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Andrographis paniculata (Andrographolide) across standard consumer modalities.

💊 Standard Capsules

The hygroscopic nature of concentrated andrographis extracts requires the inclusion of specialized glidants and moisture-protective excipients to prevent powder clumping and ensure consistent dissolution rates.

🍬 Gummy & Pectin Formats

The extreme, persistent bitterness of andrographolides necessitates advanced organoleptic masking techniques or microencapsulation to prevent the active from compromising the pectin matrix flavor profile.

🔬 Thin-Film Oral Strips

The relatively high therapeutic dose required for clinical efficacy typically exceeds the 20-40mg payload limit of standard thin-film polymer matrices, making it physically difficult to formulate as a standalone active.

For Brand Founders

Formulate with Andrographis paniculata (Andrographolide)

Ready to launch a product featuring Andrographis paniculata (Andrographolide)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Andrographis paniculata (Andrographolide) Bioavailability

Need absolute proof that your Andrographis paniculata (Andrographolide) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Andrographis paniculata (Andrographolide) Degradation Testing

Is your Andrographis paniculata (Andrographolide) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation